About Polycystic Ovarian Syndrome and Fertility
World Congress on Polycystic Ovarian Syndrome and Fertility which is scheduled during February 25-26, 2022. This conference runs with the theme “Diagnosis and Fighting with PCOS: Holding on to better women health”. We warmly invite all the speakers and delegates from around the world to attend PCOS 2021 which comprises keynote introductions, Oral talks, Poster presentations, and Exhibitions. This Event would lay an excellent opportunity to share the latest research, innovation, and discoveries in the field of Diet and PCOS, Fertility Management and Treatment, PCOS and Pregnancy, Drug Treatment, and Medication for Polycystic Ovary Syndrome, Current Trends in The Treatment of PCOS.
PCOS 2022 which displays the fundamental information about polycystic ovarian syndrome, and it gives a major clean stage to the rising advances that give a decent opportunity to the understudies to have a propelled learning. The universal regular meet of PCOS changes to happen about the Global data of Polycystic ovarian syndrome by the famous speakers that give propelled medicines and the distinctive systems to overcome the confusion. This makes the live gushing for the up and coming and the sprouting specialis
Track 1: PCOS-Women Health
Polycystic Ovarian Syndrome is triggered by hormonal secretion imbalance, one in every 10 women are generally affected. PCOS is considered one of the common reasons for infertility and is treatable. PCOS leads to hormonal imbalance in women’s bodies and affects the total health and appearance. Some common symptoms of PCOS include irregular menstrual cycle, acne, thinning of hair, darkening of skin, excess weight gain. Women throughout this condition square measure at higher risk of cardiovascular diseases, high blood pleasure, and female internal reproductive organ cancer known as (Endometrial Cancer). Utmost women with PCOS have several cysts on their ovaries. PCOS most usually remains undiagnosed. About 70% of women affected with PCOS remains undiagnosed, there is no cure for PCOS, but medications are being used to manage the symptoms of PCOS.
Track 2: PCOS and Pregnancy
The polycystic ovarian syndrome is the most common hormonal condition in women. Women with PCOS face many problems to become pregnant and are at higher risk of developing complications in pregnancy. Though, by managing the symptoms, many women with PCOS can become pregnant and have a healthy baby. Women with PCOS are three times more likely to have a miscarriage, as compared to women who don’t have PCOS. They are also more likely to develop preeclampsia,
Tracks and Key Topics
- Track 1 : PCOS-Women Health
- Track 2 : PCOS and Pregnancy
- Track 3 : PCOS and Fertility
- Track 4 : Fertility and Infertility – Women
- Track 5 : Obstetrics and Gynecology
- Track 6 : Fertility Management and Treatment
- Track 7 : In vitro fertilization (IVF)
- Track 8 : Diet and PCOS
- Track 9 : Drug Treatment and Medication for Polycystic Ovary Syndrome
- Track 10 : Endometrial Cancer
- Track 11 : Postnatal Depression
Organizing Committee Member
Polycystic Ovary Syndrome (PCOS) is a medical condition where the women of reproductive age suffer from hormonal disorders. This is due to an increase in levels of male hormones in the body which leads to an irregular menstrual cycle. The world-wide polycystic ovarian syndrome treatment market size was valued at USD 3.3 billion in 2016 and is predictable to grow at a CAGR of 5.0% over the estimated period. According to the research conducted by the American Academy of Family Physicians, approximately 7% of women of reproductive age are affected by Polycystic Ovary Syndrome (PCOS) in the U.S. Presently, no specific drug for this condition is commercially available.
The polycystic ovarian syndrome market is dominated by North America owing to the rising obesity. Other issues such as growing healthcare expenditure, increasing technological developments, and the adoption of marginally invasive surgeries drive the market growth in this region. It is assessed that Europe was the second-largest in the global polycystic ovarian syndrome market owing to the growing prevalence of obesity, diabetes, and cumulative research activities in the health manufacturing in this region. According to the German Federal Ministry of Health in 2014 and 2015, 7.0% of women age 18 and more suffered from diabetes in Germany. Thus, the increasing prevalence of diabetes in this region influences the growth of this market in this regio